These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. Petruccioli E; Najafi Fard S; Navarra A; Petrone L; Vanini V; Cuzzi G; Gualano G; Pierelli L; Bertoletti A; Nicastri E; Palmieri F; Ippolito G; Goletti D J Transl Med; 2021 Jun; 19(1):272. PubMed ID: 34174875 [TBL] [Abstract][Full Text] [Related]
3. Mild Cytokine Elevation, Moderate CD4 Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19. Wang YC; Tsai CH; Wang YC; Yen LC; Chang YW; Sun JR; Lin TY; Chiu CH; Chao YC; Chang FY Infection; 2024 Jun; 52(3):955-983. PubMed ID: 38133713 [TBL] [Abstract][Full Text] [Related]
5. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms]. Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628 [TBL] [Abstract][Full Text] [Related]
6. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract. Engelbrecht C; Sardinha LR; Rizzo LV Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443 [TBL] [Abstract][Full Text] [Related]
7. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616 [TBL] [Abstract][Full Text] [Related]
9. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. Aiello A; Najafi Fard S; Petruccioli E; Petrone L; Vanini V; Farroni C; Cuzzi G; Navarra A; Gualano G; Mosti S; Pierelli L; Nicastri E; Goletti D Int J Infect Dis; 2021 May; 106():338-347. PubMed ID: 33864921 [TBL] [Abstract][Full Text] [Related]
10. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection. Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985 [TBL] [Abstract][Full Text] [Related]
11. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2. Niu C; Liang T; Chen Y; Zhu S; Zhou L; Chen N; Qian L; Wang Y; Li M; Zhou X; Cui J Front Immunol; 2024; 15():1444643. PubMed ID: 39359733 [TBL] [Abstract][Full Text] [Related]
14. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients. Burgos-Blasco B; Güemes-Villahoz N; Santiago JL; Fernandez-Vigo JI; Espino-Paisán L; Sarriá B; García-Feijoo J; Martinez-de-la-Casa JM Exp Eye Res; 2020 Nov; 200():108253. PubMed ID: 32949577 [TBL] [Abstract][Full Text] [Related]
15. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease. Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356 [TBL] [Abstract][Full Text] [Related]
16. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave. Aiello A; Grossi A; Meschi S; Meledandri M; Vanini V; Petrone L; Casetti R; Cuzzi G; Salmi A; Altera AM; Pierelli L; Gualano G; Ascoli Bartoli T; Castilletti C; Agrati C; Girardi E; Palmieri F; Nicastri E; Di Rosa E; Goletti D Front Immunol; 2022; 13():920227. PubMed ID: 35967321 [TBL] [Abstract][Full Text] [Related]
17. [Differences in immune damage between patients with severe fever with thrombocytopenia syndrome and patients with tsutsugamushi disease]. Hu L; Kong Q; Yue C; He L; Xia L; Li J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):947-952. PubMed ID: 32912408 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994 [TBL] [Abstract][Full Text] [Related]
19. Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19. Fernandes AL; Murai IH; Reis BZ; Sales LP; Santos MD; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR Am J Clin Nutr; 2022 Mar; 115(3):790-798. PubMed ID: 35020796 [TBL] [Abstract][Full Text] [Related]
20. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset. Law JC; Girard M; Chao GYC; Ward LA; Isho B; Rathod B; Colwill K; Li Z; Rini JM; Yue FY; Mubareka S; McGeer AJ; Ostrowski MA; Gommerman JL; Gingras AC; Watts TH J Immunol; 2022 Jan; 208(2):429-443. PubMed ID: 34903642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]